Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study

BMC Urology

Volumn 15, Issue 1, 2015, Pages

  Iwamura, Hiromichi ^a   Koie, Takuya ^a   Soma, Osamu ^a   Matsumoto, Teppei ^a   Imai, Atsushi ^a   Hatakeyama, Shingo ^a   Yoneyama, Takahiro ^a   Hashimoto, Yasuhiro ^a   Ohyama, Chikara ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Chronic prostatitis chronic pelvic pain syndrome; Eviprostat; Pollen extract

Indexed keywords

CERNITIN; EVIPROSTAT; DRUG COMBINATION; ETAMSYLATE; PLANT EXTRACT;

ADULT; ARTICLE; CHRONIC PROSTATITIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PAIN ASSESSMENT; PELVIS PAIN SYNDROME; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; AGED; CHRONIC DISEASE; CHRONIC PAIN; COMPLICATION; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECTS; FEMALE; ORAL DRUG ADMINISTRATION; PAIN MEASUREMENT; PELVIC PAIN; PHYTOTHERAPY; PROCEDURES; PROSTATITIS; SECALE; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CHRONIC PAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ETHAMSYLATE; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PELVIC PAIN; PHYTOTHERAPY; PLANT EXTRACTS; PROSPECTIVE STUDIES; PROSTATITIS; SECALE; YOUNG ADULT;

EID: 84952871133     PISSN: None     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/s12894-015-0115-5     Document Type: Article

References (21)

1. Anothaisintawee T, Attia J, Nickel JC, Thammakraisorn S, Numthavaj P, McEvoy M, et al. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA. 2011;305(1):78-86.
2. Krieger JN, Nyberg Jr L, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236-7.
3. Fu W, Zhou Z, Liu S, Li Q, Yao J, Li W, et al. The effect of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) on semen parameters in human males: a systematic review and meta-analysis. PLoS One. 2014;9(4):e94991.
4. Nickel JC, Krieger JN, McNaughton-Collins M, Anderson RU, Pontari M, Shoskes DA, et al. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med. 2008;359(25):2663-73.
5. Nickel JC. Treatment of chronic prostatitis/chronic pelvic pain syndrome. Int J Antimicrob Agents. 2008;31 Suppl 1:S112-6.
6. Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Brahler E, Weidner W. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol. 2009;56(3):544-51.
7. Thakkinstian A, Attia J, Anothaisintawee T, Nickel JC. alpha-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 2012;110(7):1014-22.
8. Nickel JC, Downey J, Clark J, Casey RW, Pommerville PJ, Barkin J, et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology. 2003;62(4):614-7.
9. Bates SM, Hill VA, Anderson JB, Chapple CR, Spence R, Ryan C, et al. A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 2007;99(2):355-9.
10. Jeong CW, Lim DJ, Son H, Lee SE, Jeong H. Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination. Urol Int. 2008;80(2):157-61.
11. Nickel JC, Narayan P, McKay J, Doyle C. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol. 2004;171(4):1594-7.
12. Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, et al. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol. 2003;169(4):1401-5.
13. Oka M, Ueda M, Oyama T, Kyotani J, Tanaka M. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate. Prostate. 2009;69(13):1404-10.
14. Sugimoto M, Oka M, Tsunemori H, Yamashita M, Kakehi Y. Effect of a phytotherapeutic agent, Eviprostat(R), on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis. Prostate. 2011;71(4):438-44.
15. Tsunemori H, Sugimoto M, Xia Z, Taoka R, Oka M, Kakehi Y. Effect of the phytotherapeutic agent Eviprostat on inflammatory changes and cytokine production in a rat model of nonbacterial prostatitis. Urology. 2011;77(6):1507. e1515-1520.
16. Propert KJ, Alexander RB, Nickel JC, Kusek JW, Litwin MS, Landis JR, et al. Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology. 2002;59(6):870-6.
17. Monden K, Tsugawa M, Ninomiya Y, Ando E, Kumon H. A Japanese version of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI, Okayama version) and the clinical evaluation of cernitin pollen extract for chronic non-bacterial prostatitis. Nihon Hinyokika Gakkai Zasshi. 2002;93(4):539-47.
18. Homma Y, Tsukamoto T, Yasuda K, Ozono S, Yoshida M, Shinji M. Linguistic validation of Japanese version of International Prostate Symptom Score and BPH impact index. Nihon Hinyokika Gakkai Zasshi. 2002;93(6):669-80.
19. Bjerklund Johansen TE, Gruneberg RN, Guibert J, Hofstetter A, Lobel B, Naber KG, et al. The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol. 1998;34(6):457-66.
20. Tugcu V, Tasci AI, Fazlioglu A, Gurbuz G, Ozbek E, Sahin S, et al. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS). Eur Urol. 2007;51(4):1113-7. discussion 1118.
21. Nickel JC. Role of alpha1-blockers in chronic prostatitis syndromes. BJU Int. 2008;101 Suppl 3:11-6.